{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:17:24Z","timestamp":1786947444063,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health","award":["Small Grant Program"],"award-info":[{"award-number":["Small Grant Program"]}]},{"name":"Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health","award":["contract"],"award-info":[{"award-number":["contract"]}]},{"name":"Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health","award":["Small Grant Program"],"award-info":[{"award-number":["Small Grant Program"]}]},{"name":"Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health","award":["Small Grant Program"],"award-info":[{"award-number":["Small Grant Program"]}]},{"name":"Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health","award":["Small Grant Program"],"award-info":[{"award-number":["Small Grant Program"]}]},{"name":"Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health","award":["Small Grant Program"],"award-info":[{"award-number":["Small Grant Program"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Opioid-involved overdose continues to rise, largely explained by fentanyl adulteration of the illicit opioid supply. Fentanyl test strips are a novel drug checking tool that can be used by people who use drugs to detect the presence of fentanyl in drug products. However, it is unclear whether fentanyl test strip use can prompt behavior changes that impact risk of overdose.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this mixed-methods study involving a structured survey (<jats:italic>n<\/jats:italic>\u2009=\u2009341) of syringe service program clients in southern Wisconsin, we examined the association between fentanyl test strip use and overdose risk behaviors in scenarios where the presence of fentanyl is confirmed and unknown. Individual items were transformed into summary scales representing the performance of riskier and safer behaviors. Linear regression examined the association of behaviors with FTS use. Models are adjusted for study site, race\/ethnicity, age, gender, drug of choice, indicator of polysubstance use, times used per day, and lifetime overdose count.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In response to survey questions before prompting about fentanyl risk, people who used fentanyl test strips reported an increased number of safer (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) as well as riskier behaviors (<jats:italic>p<\/jats:italic>\u2009=\u20090.018) relative to people who did not use fentanyl test strips. The same held true in situations when fentanyl adulteration was suspected, though fentanyl test strip use lost significance in the fully adjusted model examining safer behaviors (safer: <jats:italic>p<\/jats:italic>\u2009=\u20090.143; riskier: <jats:italic>p<\/jats:italic>\u2009=\u20090.004). Among people who use fentanyl test strips, in unadjusted models, a positive test result was associated with more safer behaviors and fewer riskier behaviors, but these associations became nonsignificant in fully adjusted models (safer: <jats:italic>p<\/jats:italic>\u2009=\u20090.998; riskier: <jats:italic>p<\/jats:italic>\u2009=\u20090.171). Loss of significance was largely due to the addition of either polysubstance use or age to the model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Fentanyl test strip use is associated with behaviors that may impact overdose risk, including safer and riskier behaviors. Specifically, a positive test result may promote more risk reducing behaviors and fewer risk enhancing behaviors than a negative test result. Results suggest that while FTS may promote safer drug use behaviors, outreach and education should emphasize the need for multiple harm reduction techniques in all scenarios.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-023-00767-0","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T13:02:56Z","timestamp":1680008576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking"],"prefix":"10.1186","volume":"20","author":[{"given":"Alyssa Shell","family":"Tilhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen","family":"Zaborek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Baltes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Salisbury-Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Malicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"767_CR1","unstructured":"Baumgartner J, Radley D. The Drug Overdose Toll in 2020 and Near-Term Actions for Addressing It [Internet]. The Commonwealth Fund; 2021 Aug [cited 2021 Oct 17]. (Improving Health Care Quality). Available from: https:\/\/www.commonwealthfund.org\/blog\/2021\/drug-overdose-toll-2020-and-near-term-actions-addressing-it"},{"key":"#cr-split#-767_CR2.1","unstructured":"National Center for Health Statistics. U.S. Overdose Deaths In 2021 Increased Half as Much as in 2020 - But Are Still Up 15% [Internet]. Centers for Disease Control and Prevention"},{"key":"#cr-split#-767_CR2.2","unstructured":"2022 May [cited 2022 Sep 22]. Available from: https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2022\/202205.htm#:~:text=Provisional%20data%20from%20CDC's%20National,93%2C655%20deaths%20estimated%20in%202020."},{"issue":"8","key":"767_CR3","doi-asserted-by":"publisher","first-page":"e2226544","DOI":"10.1001\/jamanetworkopen.2022.26544","volume":"5","author":"PT Korthuis","year":"2022","unstructured":"Korthuis PT, Cook RR, Foot CA, Leichtling G, Tsui JI, Stopka TJ, et al. Association of methamphetamine and opioid use with nonfatal overdose in rural communities. JAMA Netw Open. 2022;5(8):e2226544\u2013e2226544.","journal-title":"JAMA Netw Open"},{"key":"767_CR4","unstructured":"National Institute on Drug Abuse. Overdose Death Rates [Internet]. [cited 2020 Mar 27]. Available from: https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/overdose-death-rates"},{"key":"767_CR5","doi-asserted-by":"crossref","unstructured":"Coffin PO, McMahan VM, Murphy C. Evidence of Pre-mortem Opioid Use among Fentanyl Overdose Decedents in a Safety Net Healthcare System. J Urban Health. 2022;1\u20138.","DOI":"10.1007\/s11524-022-00663-1"},{"key":"767_CR6","doi-asserted-by":"crossref","unstructured":"Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, et al. Drug checking Services for People who use Drugs: a systematic review. Addiction. 2021;","DOI":"10.32388\/TXE86U"},{"key":"767_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108976","volume":"228","author":"L Karch","year":"2021","unstructured":"Karch L, Tobias S, Schmidt C, Doe-Simkins M, Carter N, Salisbury-Afshar E, et al. Results from a mobile drug checking pilot program using three technologies in Chicago, IL, USA. Drug Alcohol Depend. 2021;228: 108976.","journal-title":"Drug Alcohol Depend"},{"key":"767_CR8","doi-asserted-by":"publisher","first-page":"102661","DOI":"10.1016\/j.drugpo.2020.102661","volume":"77","author":"TC Green","year":"2020","unstructured":"Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Int J Drug Policy. 2020;77:102661.","journal-title":"Int J Drug Policy"},{"key":"767_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","volume":"63","author":"NC Peiper","year":"2019","unstructured":"Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122\u20138.","journal-title":"Int J Drug Policy"},{"key":"767_CR10","unstructured":"Sherman SG, Park JN, Glick J, McKenzie M, Morales K, Christensen T, et al. FORECAST Study Summary Report [Internet]. Johns Hopkins Bloomberg School of Public Health; 2018. Available from: https:\/\/americanhealth.jhu.edu\/sites\/default\/files\/inline-files\/Fentanyl_Executive_Summary_032018.pdf"},{"key":"767_CR11","doi-asserted-by":"publisher","first-page":"103065","DOI":"10.1016\/j.drugpo.2020.103065","volume":"90","author":"MSS Bergh","year":"2021","unstructured":"Bergh MSS, \u00d8iestad \u00c5ML, Baumann MH, Bogen IL. Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs. Int J Drug Policy. 2021;90:103065.","journal-title":"Int J Drug Policy"},{"key":"767_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.drugpo.2019.03.003","volume":"68","author":"SG Sherman","year":"2019","unstructured":"Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BD, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46\u201353.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"767_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0213-2","volume":"15","author":"MS Krieger","year":"2018","unstructured":"Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):1\u20139.","journal-title":"Harm Reduct J"},{"issue":"1","key":"767_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0276-0","volume":"16","author":"JE Goldman","year":"2019","unstructured":"Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BD. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16(1):1\u201311.","journal-title":"Harm Reduct J"},{"key":"767_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","volume":"61","author":"MS Krieger","year":"2018","unstructured":"Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, et al. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018;61:52\u20138.","journal-title":"Int J Drug Policy"},{"key":"767_CR16","doi-asserted-by":"publisher","first-page":"102900","DOI":"10.1016\/j.drugpo.2020.102900","volume":"84","author":"NP Weicker","year":"2020","unstructured":"Weicker NP, Owczarzak J, Urquhart G, Park JN, Rouhani S, Ling R, et al. Agency in the fentanyl era: exploring the utility of fentanyl test strips in an opaque drug market. Int J Drug Policy. 2020;84:102900.","journal-title":"Int J Drug Policy"},{"key":"767_CR17","doi-asserted-by":"publisher","first-page":"103196","DOI":"10.1016\/j.drugpo.2021.103196","volume":"94","author":"JN Park","year":"2021","unstructured":"Park JN, Frankel S, Morris M, Dieni O, Fahey-Morrison L, Luta M, et al. Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs. Int J Drug Policy. 2021;94:103196.","journal-title":"Int J Drug Policy"},{"key":"767_CR18","doi-asserted-by":"publisher","first-page":"103147","DOI":"10.1016\/j.drugpo.2021.103147","volume":"92","author":"MK Reed","year":"2021","unstructured":"Reed MK, Roth AM, Tabb LP, Groves AK, Lankenau SE. \u201cI probably got a minute\u201d: perceptions of fentanyl test strip use among people who use stimulants. Int J Drug Policy. 2021;92:103147.","journal-title":"Int J Drug Policy"},{"key":"767_CR19","doi-asserted-by":"publisher","first-page":"103745","DOI":"10.1016\/j.drugpo.2022.103745","volume":"106","author":"D Goodman-Meza","year":"2022","unstructured":"Goodman-Meza D, Arredondo J, Slim S, Angulo L, Gonzalez-Nieto P, Loera A, et al. Behavior change after fentanyl testing at a safe consumption space for women in Northern Mexico: a pilot study. Int J Drug Policy. 2022;106:103745.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"767_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-022-00720-7","volume":"19","author":"AS Tilhou","year":"2022","unstructured":"Tilhou AS, Birstler J, Baltes A, Salisbury-Afshar E, Malicki J, Chen G, et al. Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin. Harm Reduct J. 2022;19(1):1\u201311.","journal-title":"Harm Reduct J"},{"key":"767_CR21","doi-asserted-by":"crossref","unstructured":"Weller S, Romney A. Defining a domain and free listing. In: Systematic data collection. Newbury Park, London, New Delhi: Sage Publications, Inc.; 1988. (Qualitative Research Methods; vol. 10).","DOI":"10.4135\/9781412986069.n2"},{"issue":"2","key":"767_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"767_CR23","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"767_CR24","unstructured":"Wisconsin Network for Research Support. CARDS [Internet]. [cited 2022 Mar 4]. Available from: https:\/\/winrs.nursing.wisc.edu\/services\/cards\/"},{"key":"767_CR25","unstructured":"Revelle WR. psych: Procedures for personality and psychological research [Internet]. Evanston, Illinois: Northwestern University; 2017 [cited 2022 Oct 5]. Report No.: R package version 2.2.9. Available from: https:\/\/cran.r-project.org\/package=psych"},{"key":"767_CR26","unstructured":"National Institute on Drug Abuse. What is drug addiction? [Internet]. 2022. Available from: https:\/\/nida.nih.gov\/publications\/drugs-brains-behavior-science-addiction\/drug-misuse-addiction"},{"key":"767_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.addbeh.2017.03.008","volume":"71","author":"JD Jones","year":"2017","unstructured":"Jones JD, Campbell A, Metz VE, Comer SD. No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone. Addict Behav. 2017;71:104\u20136.","journal-title":"Addict Behav"},{"key":"767_CR28","unstructured":"Zapata J, Tran P. Public Health Advisory: Fentanyl Increasingly Present in Overdose Deaths in Wisconsin [Internet]. Wisconsin: Wisconsin Department of Health Services; 2022 Sep [cited 2023 Jan 4]. (Public Health Advisory). Available from: https:\/\/www.dhs.wisconsin.gov\/opioids\/ph-advisory.htm"},{"key":"767_CR29","unstructured":"A field assessment of Fourier-Transform Infrared Spectroscopy (FTIR) and fentanyl immunoassay strips as point of care drug checking technologies [Internet]. British Columbia Centre on Substance Use; 2019 [cited 2022 Oct 5]. Available from: https:\/\/www.bccsu.ca\/wp-content\/uploads\/2020\/08\/FTIR_TestStrip_Field_Assessment-Sept2019.pdf"},{"issue":"1","key":"767_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-022-00590-z","volume":"19","author":"JJ Carroll","year":"2022","unstructured":"Carroll JJ, Mackin S, Schmidt C, McKenzie M, Green TC. The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19. Harm Reduct J. 2022;19(1):1\u201313.","journal-title":"Harm Reduct J"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00767-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00767-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00767-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T13:08:07Z","timestamp":1680008887000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00767-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00767-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"11 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board at the University of Wisconsin School of Medicine and Public Health. All respondents provided informed consent prior to participation in both study phases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}